CPR:MILDavide Campari-Milano N.V. Analysis

Campari shares trade around €5.58, just above the 20‑day SMA of €5.52 but still under the 50‑day SMA of €5.96, indicating a short‑term price cushion. RSI sits at 46, suggesting neutral momentum, while the MACD histogram turned positive and the signal line is bullish, hinting at a modest upside. Volatility is elevated at over 51% for the past 30 days, yet the beta is exceptionally low, implying limited market‑wide risk. The stock’s trailing PE of 19 and forward PE of 16 sit near industry averages, and a dividend yield of 1.81% with a payout ratio of 22% underscores a sustainable income stream. Free cash flow of roughly €317 M and operating cash flow of €688 M provide a solid liquidity base despite a debt‑to‑equity ratio near 70%. Analysts project a median target of €6.70, translating to an estimated upside of about 20% from current levels, reinforced by a “buy” consensus from 21 analysts.
The DCF‑derived fair value appears low, but the broader valuation metrics and the 24.5% upside/downside estimate point to the stock being undervalued relative to peers. Consumer‑defensive positioning in the beverages sector offers resilience amid macro volatility, and the company’s diversified geographic footprint mitigates single‑region exposure. With modest revenue contraction of 2.8% offset by strong gross margins (60%) and an operating margin of 17%, earnings quality remains intact. The balance sheet shows ample cash (€714 M) against €2.7 B of debt, and a ROE of 8.6% suggests reasonable return generation. Overall, the blend of technical softness, attractive valuation spread, and solid fundamentals supports a positive outlook across horizons.